Hunter Robyn

Hunter Robyn is listed in filings as Director at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including 1 public disclosure. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX). The current snapshot covers public activity from Jan 13, 2026. Reported amounts are shown as $399.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.